Roche’s Lucentis Effective for Diabetic Retinopathy

Shares

A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular degeneration. According to EurekAlert the study found that treating diabetic macular edema (DME) with Roche’s ranibizumab (Lucentis) eye injections, plus laser treatment if needed, appears to result in better vision than laser treatment alone. DME is the main cause of vision loss in people with diabetes mellitus.

0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
Copyright © 2009-2020 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.
DMCA Compliant
0
Would love your thoughts, please comment.x
()
x